INTERNATIONAL PATENT: CONTERA PHARMA A/S FILES APPLICATION FOR "DELAYED DUAL-PULSE ORAL FORMULATION"

GENEVA, Aug. 24 -- CONTERA PHARMA A/S (Venlighedsvej 42970 Horsholm) filed a patent application (PCT/EP2025/053697) for "DELAYED DUAL-PULSE ORAL FORMULATION" on Feb 12, 2025. With publication no. WO/2025/172348, the details related to the patent application was published on Aug 21, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ISLAM, Muhammad Tariqul (c/o BDD Pharma Ltd84 Castle StreetGlasgow G4 0SF), CHRISTENSEN, Kenneth Vielsted (c/o Contera Pharma A/SVenlighedsvej 42970 Horsholm), HOLM, Rene (Skolegyden 285792 Arslev)

Abstract: Provided is a pulsatile drug delivery system that enable...